PBMD up 1000% in the past two days because of the clinical results from CVAC ovarian cancer phase 2B trials. Nothing to do with RNAi or Benitec but we could most likely experience a similar rise once efficacy is demonstrated in TT-034 or Tribetarna.
http://cnafinance.com/prima-biomed-pbmd-stock-continues-to-climb-can-it-last/3386
- Forums
- ASX - By Stock
- J&J pays 1.1B for Achillion Hep C line
PBMD up 1000% in the past two days because of the clinical...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)